The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-20.4% to $15.80
Predicted High$20.40at 1 month
Predicted Low$15.80at 6 months
Max Drawdown (predicted)-20.4%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 1, 2026 1:01 am
Bear
OMDA trends lower to
$15.80
(-20.4% from $19.84)
by Feb 2027.
ride-then-fade
ThesisOMDA has strong price momentum (32% trailing 6m) and consistent EPS beats, but weak value/quality scores and a risk-off tape create tension. Expect momentum to carry the name modestly higher near-term before value gravity and unprofitable digital-health skepticism pull it back toward the mid-teens attractive zone over the six-month horizon.
Invalidated ifA sustained break above $23 on volume, or conversely a break below $15 that fails to recover within two weeks, would falsify this fade path.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $19.84 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 1, 2026
—
$19.84at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 15, 2026
$17.84–$21.84typical range · internal point $20.15
—
±10.1%
6/10
Momentum and beat streak carry price slightly higher
What actually happened:
closed $24.04
on Aug 14, 2026 = +21.2% vs the call
(predicted +1.6%)
· direction MISS
(called flat, was up)
· off by 19.6 pp
· accuracy 4/10
· typical range ±10.1%:
OUTSIDE the band
· S&P +4.0%
over the same window — lagged it
1 month
Sep 1, 2026
$16.94–$22.74typical range · internal point $20.40
—
±14.6%
5/10
Momentum peaks as risk-off tape starts biting
What actually happened:
closed $22.84
on Sep 1, 2026 = +15.1% vs the call
(predicted +2.8%)
· direction MISS
(called flat, was up)
· off by 12.3 pp
· accuracy 4/10
· typical range ±14.6%:
OUTSIDE the band
· S&P +1.9%
over the same window — beat it
2 months
Oct 1, 2026
$19.60
—
-1.2%
5/10
Sentiment drag begins, no catalyst to defend price
3 months
Nov 1, 2026
$18.50
—
-6.8%
5/10
Value gravity engages, unprofitable narrative under pressure
4 months
Dec 1, 2026
$17.20
—
-13.3%
5/10
Continued fade toward attractive-below level
5 months
Jan 1, 2027
$16.30
—
-17.8%
4/10
Approaches value zone, potential stabilization buyers
6 months
Feb 1, 2027
$15.80
—
-20.4%
4/10
Settles near value threshold as fade completes
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.